Valueworks LLC Eli Lilly & CO Transaction History

Valueworks LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $6.36 Million - $7.49 Million	-57,169 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $555,869 - $622,741	-5,249 Reduced 8.41%	57,169 $66.2 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $523,059 - $653,732	-6,092 Reduced 8.89%	62,418 $6.7 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $159,348 - $182,882	-2,105 Reduced 2.98%	68,510 $5.85 Million
Q1 2018 May 17, 2018	BUY	$74.21 - $87.6 $64,043 - $75,598	863 Added 1.24%	70,615 $5.46 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $133,316 - $142,997	1,627 Added 2.39%	69,752 $5.89 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $60,114 - $66,721	780 Added 1.16%	68,125 $5.83 Million
Q2 2017 Aug 15, 2017	BUY	N/A	67,345	67,345 $5.54 Million

3,912

765M

6.35M

7.96M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $778B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Valueworks LLC, based on Form 13F filings with the SEC.

Stay updated on Valueworks LLC with notifications on news.